Typical Candidate Profile: BMI of 30 or higher (obese), or BMI of 27+ with at least one weight-related condition (hypertension, type 2 diabetes, high cholesterol) Have not achieved significant results with diet and exercise alone Looking for a medically supervised weight loss approach No contraindications such as personal or family history of medullary thyroid carcinoma or MEN2 The LightRx Process: 1
Theres a rationale behind localized injection: some practitioners use it near a specific treatment area on the theory that proximity might concentrate effects locally
Delivery country: currently we only deliver to the USA, Canada, Australia, the UK, New Zealand
However, the pharmacokinetics of hydrocortisone can vary by 10 times from patient to patient
Studies show that people taking GLP-1-based therapy (including exenatide, liraglutide, dulaglutide, semaglutide, or tirzepatide) are four times more likely to have food stuck in their stomachs during endoscopy (13.6% versus 2.3% in non-users) [6]
With those caveats in place, here is what the data and community sources describe at each phase
